Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts cardiovascular disease: the Kailuan prospective cohort study
- PMID: 38838914
- DOI: 10.1016/j.hjc.2024.05.002
Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts cardiovascular disease: the Kailuan prospective cohort study
Abstract
Objective: Previous studies have shown that remnant cholesterol (RC) is associated with cardiovascular disease (CVD). The study aimed to identify the association of RC and the discordance between RC and lipoprotein cholesterol (LDL-C) with CVD.
Methods: Data were obtained from the Kailuan study. RC was calculated as the non-high-density lipoprotein cholesterol minus LDL-C. Discordant RC and LDL-C were defined by percentile difference and clinical cut-off points. Cox proportional hazard models were used to explore the association of RC and the discordance between RC and LDL-C with CVD.
Results: A total of 96,769 participants were included, with a median age of 51.61 years and 79.56% were male. There was a significant association between RC levels and the risk of CVD, with an HR of 1.10 (95% CI, 1.08-1.13) in the continuous analysis. The group with a discordantly high RC had a significant increase in CVD, MI, and stroke risk, with HRs of 1.18 (95% CI, 1.10-1.26), 1.23 (1.06-1.43), and 1.15 (1.07-1.24), respectively. Compared with the group with low LDL-C and low RC, the group with low LDL-C and high RC had significantly higher incidences of CVD (HR, 1.33 [95% CI, 1.26-1.40]), MI (HR, 1.59 [95% CI, 1.41-1.80]), and stroke (HR, 1.28 [95% CI, 1.20-1.35]).
Conclusions: Elevated levels of RC and discordantly high RC with LDL-C were associated with the risk of CVD, MI, and stroke. These findings demonstrate the clinical significance of identifying residual risk related to RC.
Keywords: Cardiovascular disease; Cohort study; Low-density lipoprotein cholesterol; Primary prevention; Remnant cholesterol.
Copyright © 2024 Hellenic Society of Cardiology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Competing interest The authors declare no competing interests.
Similar articles
-
The role of remnant cholesterol in patients with ST-segment elevation myocardial infarction.Eur J Prev Cardiol. 2024 Aug 9;31(10):1227-1237. doi: 10.1093/eurjpc/zwae102. Eur J Prev Cardiol. 2024. PMID: 38447015
-
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.Eur Heart J. 2021 Nov 7;42(42):4324-4332. doi: 10.1093/eurheartj/ehab432. Eur Heart J. 2021. PMID: 34293083 Free PMC article.
-
Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts arterial stiffness progression.Hellenic J Cardiol. 2023 Nov-Dec;74:24-31. doi: 10.1016/j.hjc.2023.05.008. Epub 2023 May 26. Hellenic J Cardiol. 2023. PMID: 37245643
-
Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis.Atherosclerosis. 2023 Apr;371:21-31. doi: 10.1016/j.atherosclerosis.2023.03.012. Epub 2023 Mar 21. Atherosclerosis. 2023. PMID: 36966562
-
Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol.J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231189597. doi: 10.1177/10742484231189597. J Cardiovasc Pharmacol Ther. 2023. PMID: 37641208 Review.
Cited by
-
Two-Year Changes in Remnant Cholesterol and Stroke Risk in the Chinese Population: A Prospective Cohort Study.J Am Heart Assoc. 2025 Jun 3;14(11):e038559. doi: 10.1161/JAHA.124.038559. Epub 2025 May 22. J Am Heart Assoc. 2025. PMID: 40401619 Free PMC article.
-
Association between remnant cholesterol and low-density lipoprotein cholesterol discordance and type 2 diabetes or prediabetes: results from NHANES.BMC Endocr Disord. 2025 Jul 7;25(1):168. doi: 10.1186/s12902-025-01995-0. BMC Endocr Disord. 2025. PMID: 40624651 Free PMC article.
-
Longitudinal changes in remnant cholesterol and the risk of cardiovascular disease.Cardiovasc Diabetol. 2025 Jan 2;24(1):1. doi: 10.1186/s12933-024-02556-w. Cardiovasc Diabetol. 2025. PMID: 39748387 Free PMC article.
LinkOut - more resources
Full Text Sources